Variants in LDLR-3′UTR could cause hypercholesterolemia by removing miRNA binding, while PCSK9-3′UTR variants could upregulate PCSK9 by adding illegitimate binding sites. This evidence concerns the gene PCSK9 and familial hypercholesterolemia.